This is the second patent application of 2008 which was made pursuant to Kraig’s sponsored research program at the University of Notre Dame and which is subject to Kraig’s intellectual property agreement with the University. That agreement provides for exclusive licensing rights for Kraig sponsored research. It is the first such patent application made pursuant to that program relating to human health.
Dr. Fraser said: “One of the advantages of a polymer based diagnostic platform is its ability to incorporate multiple antigens into a final product simply by weaving the polymers. The result would be a diagnostic tool which could simultaneously screen for several diseases or for other important parameters.”